Protalix BioTherapeutics
PLX
$1.15
Share price
-2.54%
Change (1 day)
-58.63%
Change (1 year)
Categories
Protalix BioTherapeutics (PLX) - Net assets
Net assets on the balance sheet as of December 2023 : $33.56 M
According to Protalix BioTherapeutics
's latest financial reports the company has $33.56 M in net assets.
A company’s net assets is the sum of its assets minus the sum of its liabilities.
Protalix BioTherapeutics - Net assets on balance sheet (from 2001 to 2023)
Net assets by year
| Year | Net assets | Change |
|---|---|---|
| 2023-12-31 | $33.56 M | -415.5% |
| 2022-12-31 | $-10.64 M | 76.28% |
| 2021-12-31 | $-6.04 M | -77.68% |
| 2020-12-31 | $-27.04 M | -61.55% |
| 2019-12-31 | $-70.33 M | 32.98% |
| 2018-12-31 | $-52.89 M | 79.52% |
| 2017-12-31 | $-29.46 M | 195.84% |
| 2016-12-31 | $-9.96 M | -191.58% |
| 2015-12-31 | $10.87 M | -119.56% |
| 2014-12-31 | $-55.61 M | 106.34% |
| 2013-12-31 | $-26.95 M | 702.68% |
| 2012-12-31 | $-3.36 M | -87.13% |
| 2011-12-31 | $-26.08 M | 130.3% |
| 2010-12-31 | $-11.33 M | -171.29% |
| 2009-12-31 | $15.88 M | -64.18% |
| 2008-12-31 | $44.34 M | -30.37% |
| 2007-12-31 | $63.68 M | 162.25% |
| 2006-12-31 | $24.28 M | 298.42% |
| 2005-12-31 | $6.09 M | 1131.31% |
| 2004-12-31 | $0.49 M | -24.48% |
| 2003-12-31 | $0.65 M | -17.67% |
| 2002-12-31 | $0.79 M | -15.83% |
| 2001-12-31 | $0.94 M |
Net assets for similar companies or competitors
| Company | Net assets | differencediff. | Country |
|---|---|---|---|
 Pfizer PFE | $89.28 B | 265,883.50% | 🇺🇸 USA |
 Neurocrine Biosciences
NBIX | $2.23 B | 6,548.99% | 🇺🇸 USA |
 Amicus Therapeutics
FOLD | $0.16 B | 377.15% | 🇺🇸 USA |
 Teva Pharmaceutical Industries TEVA | $8.12 B | 24,106.86% | 🇮🇱 Israel |